Blood samples
Pre-clinicalTerminated 0 watching 0 views this week💤 Quiet
22
Development Stage
1
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Non-Alcoholic Fatty Liver Disease
Conditions
Non-Alcoholic Fatty Liver Disease, Chronic Kidney Diseases, PreDiabetes, Kidney Transplant
Trial Timeline
May 29, 2019 → Mar 31, 2022
NCT ID
NCT03866421About Blood samples
Blood samples is a pre-clinical stage product being developed by Novo Nordisk for Non-Alcoholic Fatty Liver Disease. The current trial status is terminated. This product is registered under clinical trial identifier NCT03866421. Target conditions include Non-Alcoholic Fatty Liver Disease, Chronic Kidney Diseases, PreDiabetes.
Hype Score Breakdown
Clinical
5
Activity
2
Company
9
Novelty
2
Community
1
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT03866421 | Pre-clinical | Terminated |
Competing Products
20 competing products in Non-Alcoholic Fatty Liver Disease